Filing Flows › Tandem Diabetes Care (TNDM) › Free cash flow
Tandem Diabetes Care (TNDM) free cash flow by quarter
Tandem Diabetes Care's free cash flow was $4.8M in Q1 2026 (first quarter 2026), +54% from Q4 2025. Over the last 3 quarters it ranged from $3.1M (Q4 2025) to $4.8M (Q1 2026).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q1 2026 | $4.8M | +54% | — |
| Q4 2025 | $3.1M | -26% | — |
| Q3 2025 | $4.2M | — | — |
Q1 2026 at a glance
Tandem Diabetes Care, Q1 2026: revenue $247M (+6% year over year), operating margin -7.1%, net loss $20.4M, operating cash flow $11.1M. The chart follows the revenue to costs, profit and cash.
Questions
What is Tandem Diabetes Care's free cash flow?
Tandem Diabetes Care's free cash flow was $4.8M in Q1 2026 (first quarter 2026), +54% from Q4 2025.
How has Tandem Diabetes Care's free cash flow changed?
Over the last 3 quarters it ranged from $3.1M (Q4 2025) to $4.8M (Q1 2026).